(Reuters) - The incipient migration of clients from Credit Suisse to UBS should take about another 18 months, UBS CEO Sergio ...

With a focus on cancer and autoimmune conditions, UBS has launched its coverage of 13 small and mid-cap biotechs, noting that ...

UBS lowered the firm’s price target on Moderna (MRNA) to $108 from $140 and keeps a Buy rating on the shares following a model review.

UBS analyst Justin Forsythe maintained a Sell rating on Worldline (0QVI – Research Report) today and set a price target of €5.25. The ...

Five UBS Wealth Management USA financial advisers based in the firm’s Pacific Desert Market have been named to the Forbes Top ...

Burish attributes much of his group’s success to its stability – Maas may be the only team member who’s been there since he ...

Both Hardin and O’Hara join UBS’s Integra Partners, a private wealth management group led by advisors Vicente Del Rio, Brian ...

Market volatility can be overwhelming, leading some investors to head for the exits and sit in cash. While this seems like a ...

Jim Kosan, financial advisor for ultra high net worth clients, switches from Morgan Stanley to UBS, joins Riverside office. Pat Lizza welcomes him.

In a deal that has reshaped Hong Kong’s IPO landscape, China’s home-appliance giant Midea successfully raised $4.6 billion in ...

According to this year’s edition of the UBS Global Real Estate Bubble Index, bubble risk in housing markets declined further. Miami now shows the highest bubble risk among the cities in this study, ...

Swiss financial regulator FINMA has urged UBS to enhance its emergency measures to improve readiness in potential insolvency ...